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The II* Genoa Meeting on Hypertension, Diabetes, and who have actively participated in the development of
Renal Diseases, organized by Giacomo Deferrari, will replacement therapies, ranges from extracorporeal renal
be held February 28–March 1, 2003, in Genoa, Italy. The replacement therapies to treatment strategies for end-
deadline for abstract submission is December 15, 2002. stage renal failure in developing countries. Each chapter
For further information, contact: Roberto Pontremoli, is well-written and is accompanied by tables and illustra-
M.D., Department of Internal Medicine, Section of tions. In addition, each chapter includes an exhaustive
Nephrology, University of Genoa, Italy. Fax: 39-010- list of references and there is a comprehensive subject
353-8959; E-mail: rpontrem@medicina.unige.it; Web site: index at the end of the text. The price of this text is
http://www.aristea.com/diredi03 $139.50.
The Eighth International Conference on Continuous Myths and Shibboleths in Nephrology, edited by Eli A.
Renal Replacement Therapies will be held March 6–8, Friedman and Iram Anees. Dordrecht, The Netherlands:
2003, at the Hotel del Coronado in Coronado (San Diego), Kluwer Academic Publishers, 2002. ISBN (hardback):
California. The deadline for abstract submission is Decem- 1-4020-0615-2; ISBN (paperback): 1-4020-0616-0. This
ber 6, 2002. For further information, contact: Shirley Kol- 74-page text succinctly dissects 26 myths and shibboleths
key, Complete Conference Management, 1660 Hotel Cir-
that relate to the study of nephrology. In their Preface,cle North, #220, San Diego, CA 92108. Telephone: (619)
the editors define the term “myths,” using Webster’s299-6673; Fax: (619) 299-6675; E-mail: c-c-m@worldnet.
New Collegiate Dictionary, as a “traditional story, popu-att.net; CRRT Web site: http://www.crrtonline.com
lar belief or notion of explaining a practice or natural
phenomenon that may be unfounded or false.” “A shib-
BOOKS RECEIVED boleth is a commonplace idea or saying (from the He-
brew meaning torrent of water), whose accuracy in pro-Optimal Treatment Strategies in End-Stage Renal Fail-
nunciation was originally employed to distinguish oneure, edited by Claude Jacobs. New York: Oxford Univer-
tribe from another (Judges 12:4–6), and today signifiessity Press, 2002. ISBN: 0-19-262971-9. In the Preface to
a custom or practice that has gained acceptable usage.”this 11-chapter text, the editor comments that 40 years
The 26 myths in this text range from urinary tract diseaseago, when he was a young nephrologist in training, he had
leading to end-stage renal disease to hemofiltration beingto learn “how to ensure patients with terminal uremia a
superior to hemodialysis in the treatment of certain poi-peaceful, painless death within a few weeks’ time. At
sonings and/or drug overdoses. Each myth is analyzedpresent, he enjoys meeting some of his patients who are
by one of the 19 contributors who cite both the pros andalive and well several decades after having started some
cons of the myth and then offer a conclusion as to itsform of renal replacement therapy, while more than a
validity. Each contribution also includes selected refer-million patients world-wide are currently benefiting from
ences. The price of the hardback copy of this text isthese life-saving procedures.” The content of this text,
written by 18 contributors from throughout the world $62.00 US, 69 Eur, and 44 GBP.
THE ALBERT LASKER AWARD FOR CLINICAL MEDICAL RESEARCH
Presented to Willem J. Kolff and Belding H. Scribner
For the development of renal hemodialysis, which changed kidney failure
from a fatal to a treatable disease, prolonging the useful lives of millions of patients.
This year’s Lasker Clinical Medical Research Award honors two scientists who changed kidney failure from a
fatal to a treatable disease. By developing the artificial kidney and devising a system for repeating hemodialysis
over a period of months and even years, Willem J. Kolff and Belding H. Scribner, respectively, have prolonged the
useful lives of millions of people.
The fate of kidney patients has undergone a revolution in the last half century, due in large part to Kolff’s and
Scribner’s seminal contributions. The kidney filters metabolic byproducts from the blood, and when it fails, patients
suffer from a variety of symptoms, including weight loss, nausea and vomiting, gastrointestinal hemorrhaging, itching,
lethargy, convulsions, and coma. Without treatment, death ensues. Hemodialyzers replace the cleansing capabilities
of the kidney, and although the organ performs other physiological tasks as well, the machine’s ability to extract
impurities bestows vitality upon formerly doomed individuals.
In the late 1930s, Kolff decided to devise a contraption that would clean tainted blood from acutely ill patients,
thereby ushering them through brief periods of time in which their kidneys failed to function. Today, a variety of
